Flexion Therapeutics Inc is categorized under in Burlington, MA and active since 2007.
Flexion Therapeutics Inc was established in 2007, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Michael Clayman, Chief Executive Officer at the company’s single location by writing to 10 Mall Road # 300, Burlington, Massachusetts MA 01803 or by phoning (781) 897-9977. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Flexion Therapeutics Inc |
| Contact Person: | Michael Clayman, Chief Executive Officer |
| Address: | 10 Mall Road # 300, Burlington, Massachusetts 01803 |
| Phone Number: | (781) 897-9977 |
| Website Address: | flexiontherapeutics.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 3254120 |
| Share This Business: |
Flexion Therapeutics Inc was started in 2007 to provide professional under the SIC code 2834 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Michael Clayman, Chief Executive Officer for inquiries that concern Flexion Therapeutics Inc by calling the company number (781) 897-9977, as your correspondence is most welcome. Additionally, the physical location of the single location of Flexion Therapeutics Inc can be found at the coordinates 42.49118,-71.19569 as well as the street address 10 Mall Road # 300 in Burlington, Massachusetts 01803.
For its online presence, you may visit Flexion Therapeutics Inc’s website at flexiontherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.